Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.44M Buy
23,296
+174
+0.8% +$59.6K 0.1% 61
2026
Q1
$8.14M Sell
23,122
-417
-2% -$149K 0.1% 56
2025
Q4
$7.7M Sell
23,539
-65
-0.3% -$20.6K 0.09% 60
2025
Q3
$6.66M Sell
23,604
-29
-0.1% -$8.41K 0.08% 68
2025
Q2
$6.6M Buy
23,633
+278
+1% +$78.8K 0.08% 66
2025
Q1
$7.28M Buy
23,355
+253
+1% +$74.7K 0.09% 63
2024
Q4
$6.02M Sell
23,102
-586
-2% -$174K 0.08% 69
2024
Q3
$7.63M Buy
23,688
+1,309
+6% +$428K 0.09% 61
2024
Q2
$6.99M Sell
22,379
-2,644
-11% -$777K 0.09% 63
2024
Q1
$7.11M Buy
25,023
+2,474
+11% +$724K 0.09% 62
2023
Q4
$6.49M Buy
22,549
+650
+3% +$177K 0.09% 62
2023
Q3
$5.89M Buy
21,899
+88
+0.4% +$22K 0.09% 61
2023
Q2
$4.84M Buy
21,811
+230
+1% +$53.4K 0.07% 64
2023
Q1
$5.22M Buy
21,581
+191
+0.9% +$46.9K 0.08% 65
2022
Q4
$5.62M Buy
21,390
+663
+3% +$178K 0.1% 65
2022
Q3
$4.67M Buy
20,727
+25
+0.1% +$6.06K 0.09% 65
2022
Q2
$5.04M Sell
20,702
-1,001
-5% -$245K 0.09% 69
2022
Q1
$5.25M Sell
21,703
-752
-3% -$173K 0.07% 72
2021
Q4
$5.05M Buy
22,455
+444
+2% +$93.7K 0.07% 75
2021
Q3
$4.68M Buy
22,011
+386
+2% +$88.8K 0.07% 73
2021
Q2
$5.27M Buy
21,625
+310
+1% +$76.3K 0.08% 68
2021
Q1
$5.3M Buy
21,315
+1,519
+8% +$362K 0.09% 66
2020
Q4
$4.55M Sell
19,796
-177
-0.9% -$40.8K 0.08% 68
2020
Q3
$5.08M Sell
19,973
-238
-1% -$59K 0.1% 65
2020
Q2
$4.77M Buy
20,211
+46
+0.2% +$10.5K 0.11% 64
2020
Q1
$4.09M Buy
20,165
+1,793
+10% +$392K 0.11% 62
2019
Q4
$4.43M Buy
18,372
+151
+0.8% +$33.3K 0.1% 71
2019
Q3
$3.53M Sell
18,221
-100
-0.5% -$19.2K 0.09% 77
2019
Q2
$3.38M Hold
18,321
0.08% 77
2019
Q1
$3.48M Buy
18,321
+1
+0% +$191 0.09% 75
2018
Q4
$3.57M Buy
18,320
+200
+1% +$39K 0.1% 67
2018
Q3
$3.76M Buy
18,120
+201
+1% +$39.6K 0.09% 69
2018
Q2
$3.31M Sell
17,919
-250
-1% -$44.2K 0.09% 72
2018
Q1
$3.1M Buy
18,169
+2,990
+20% +$549K 0.09% 74
2017
Q4
$2.64M Buy
15,179
+151
+1% +$26.7K 0.07% 87
2017
Q3
$2.8M Sell
15,028
-250
-2% -$44.3K 0.08% 80
2017
Q2
$2.63M Buy
15,278
+158
+1% +$25.7K 0.08% 85
2017
Q1
$2.48M Buy
15,120
+1
+0% +$166 0.08% 84
2016
Q4
$2.21M Sell
15,119
-320
-2% -$48.2K 0.08% 91
2016
Q3
$2.58M Sell
15,439
-151
-1% -$25.5K 0.09% 93
2016
Q2
$2.37M Sell
15,590
-174
-1% -$27.1K 0.08% 96
2016
Q1
$2.36M Sell
15,764
-100
-0.6% -$14.9K 0.09% 101
2015
Q4
$2.58M Hold
15,864
0.09% 95
2015
Q3
$2.19M Buy
15,864
+76
+0.5% +$12K 0.08% 101
2015
Q2
$2.42M Hold
15,788
0.09% 95
2015
Q1
$2.52M Buy
15,788
+78
+0.5% +$12.3K 0.09% 95
2014
Q4
$2.5M Buy
15,710
+120
+0.8% +$18.7K 0.09% 94
2014
Q3
$2.19M Buy
15,590
+200
+1% +$26.1K 0.08% 97
2014
Q2
$1.82M Sell
15,390
-100
-0.6% -$11.6K 0.07% 96
2014
Q1
$1.91M Hold
15,490
0.07% 88
2013
Q4
$1.77M Hold
15,490
0.07% 86
2013
Q3
$1.73M Sell
15,490
-100
-0.6% -$10.8K 0.07% 84
2013
Q2
$1.54M Buy
+15,590
New +$1.62M 0.06% 87

Other funds holding AMGN

Everett Harris & Co's AMGN Position: Q2 2026 in Review

Everett Harris & Co increased its Amgen (AMGN) stake by 0.75% in Q2 2026, buying an estimated $59.6K and bringing the position to 23,296 shares worth $8.44M. The position accounts for 0.1% of the portfolio, ranked #61.

Everett Harris & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Everett Harris & Co held 23,296 shares of Amgen worth $8.44M as of Q2 2026.
  • Everett Harris & Co bought 174 Amgen shares in Q2 2026, an estimated $59.6K.
  • Amgen made up 0.1% of Everett Harris & Co's portfolio in Q2 2026, its #61 holding.
  • Everett Harris & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Everett Harris & Co's 13F filing for Q2 2026, filed 3 Aug 2026.